Waters’ new AI tool targets one of the pharmaceutical industry’s most tedious tasks
Source: Fortune ·
Waters took one-and-a-half years to develop its new AI tool, which it says will cut manual drug-testing work performed by scientists by 95%.
From the source
Brook Colangelo, chief information officer at Waters Corp., says the lab equipment company’s newest artificial intelligence tool can help drugmakers speed up their quality testing processes. On Wednesday, Waters debuted a new AI-powered integration called Peak Integration into its Empower software platform to drastically reduce manual interventions traditionally performed by scientists for quality assurance (QA) and quality control (QC) in drug discovery and manufacturing. These QA/QC processes ensure medicines are safe, effective, and compliant with the Food and Drug Administration and other regulatory standards. Waters says that the new AI and machine learning capabilities within Empower—which has 500,000 users and supports the release of popular drugs ranging from aspirin to Wegovy—can reduce manual interventions by 95%. Waters also says that the new AI feature improves testing accuracy by 76% and is 50% faster than the prior process. “The advancements here are around how we take…